RESOURCES

Useful Resources

Canadian Society of Nephrology (CSN)

CSN Guidelines

CSN Community Webinars

Kidney Disease Improving Global Outcomes (KDIGO)

KDIGO Guidelines

Kidney Foundation of Canada

Canadian Journal of Kidney Health and Disease

Diabetes Canada CKD Guidelines

Learn how UACR testing can reveal early kidney damage and act as a predictor of CKD progression8

Find out here

Stay up to date on the latest developments in CKD and T2D

Sign up for updates and new information from Bayer on CKD and T2D.

CKD: chronic kidney disease; T2D: type 2 diabetes; UACR: urine albumin-to-creatinine ratio.

Reference

8. Levin A, Stevens PE, Bilous RW, et al. (2013). Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements, 3(1), 1-150. https://doi.org/10.1038/kisup.2012.73

© 2021 Bayer Inc.

Last updated on July 14, 2020 (Release 2.1)

This website is intended to provide information to Canadian healthcare professionals.

  • PP-FINE-CA-0035-1
Alt tag Alt tag